Skip to main content
OpenTrials
Completed

NCT Number: NCT05730920

IV Methadone Vs EXPAREL Erector Spinae Plane Blockade in Pediatric Subjects Undergoing Idiopathic Scoliosis Correction

The goal of this pilot study is to assess the feasibility of conducting a randomized controlled trial at a single institution comparing erector spinae plane blockade (ESPB) with liposomal bupivacaine (LB, Exparel) to intravenous (IV) methadone for managing pain in pediatric subjects undergoing adolescent and juvenile idiopathic scoliosis correction. Specifically, the goal is to enroll 15 subjects in each group and to complete data collection for all subjects. If this pilot study is successful, we plan to then design a larger scale study powered to compare specific outcomes between the two groups.

Completed

Looking for future studies?

Notify Me

Key information

Age range

11 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Shriners Hospitals for Children

Sacramento, California, 95817, United States

About this study

Enrolled subjects will be randomized to one of two groups: one group will receive intra-operative IV methadone as the primary means of controlling post-operative pain while the other group will instead receive intra-operative erector spinae plane blocks (ESPB) with liposomal bupivacaine (LB, Exparel) and bupivacaine hydrochloride as the primary means of controlling postoperative pain. All other aspects of peri-operative management will be standardized. Subjects and the post-operative care team will be blinded to which intervention was performed in order to reduce bias. Upon discharge, subjects will receive a wearable activity monitor and a daily journal in order to record post-discharge data. Subjects will receive weekly phone calls for data collection and then will have a final in-person clinic visit, at which point participation in the study will conclude.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects whose parent(s) or guardian(s) has/have signed and dated the informed consent form (ICF) for the subject to participate in the study
  • Patients with a diagnosis of juvenile idiopathic scoliosis (JIS) or adolescent idiopathic scoliosis (AIS) who will have posterior spinal fusion surgery
  • Male or female patients 11 to less than 18 years of age on the day of surgery.
  • American Society of Anesthesiologists (ASA) Class 1-2.
  • Able to adhere to the study visit schedule and complete all study assessments.

Exclusion criteria

  • Body mass index ≥35 at the time of screening
  • Contraindication to regional anesthesia (e.g., abnormal coagulation, infection at site)
  • Current opioid use at the time of screening
  • Current diagnosis of chronic pain
  • Allergy, hypersensitivity, intolerance, or contraindication to any of the study medications
  • Administration of liposomal bupivacaine (LB, Exparel)
  • Subject/parent/guardian primary language other than English or Spanish
  • Inability of patient to verbally express symptoms such as pain and side effects (as in moderate to severe developmental delay)
  • A prolonged QTc on preoperative EKG (QTc longer than 450 milliseconds)
  • History of Torsades de Pointes
  • Renal or hepatic impairment
  • Diagnosed active seizure disorder
  • Any other condition that causes patient to be ineligible for surgery, i.e. pregnancy.

Treatment and study plan

Methadone

Drug

IV Methadone

Liposomal bupivacaine (LB, Exparel)

Drug

LB and bupivacaine hydrochloride via erector spinae plane blocks

Primary outcomes

  1. Successful Enrollment and Data Collection of 30 Subjects

    Time frame: 2 years

    Assess the feasibility of completing a prospective randomized trial pilot study comparing Erector Spinae Plane Blockade (ESPB) with liposomal bupivacaine (LB) to intravenous methadone at a single institution in two years

Secondary outcomes

  1. Opioid Consumption

    Time frame: 2 years

    Assess whether there is a difference in post-operative opioid consumption between the two study groups. This will evaluated by converting all long-acting opioids to daily morphine equivalents per unit of weight.

  2. Pain Scores

    Time frame: 2 years

    Assess whether there is a difference in post-operative pain scores between the two study groups. Visual analog scale (VAS) scores with a minimum of 0 and a maximum of 10 will be used where 0 is no pain and 10 is the worst pain imaginable

  3. Length of Stay

    Time frame: 2 years

    Assess whether there is a difference in hospital length of stay between the two study groups

Sponsors and collaborators

Lead sponsor

Dr. Casey Stondell, MD

Other

Collaborators

  • Pacira Pharmaceuticals, Inc

Registry information

Official study title

A Single-center, Randomized, Single-blind Pilot Study to Evaluate Intravenous Methadone Versus EXPAREL Erector Spinae Plane Blockade in Pediatric Subjects Undergoing Adolescent and Juvenile Idiopathic Scoliosis Correction

Acronym: AIMS

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Feb 16, 2023
Registry last updated
Oct 4, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.